Why More Americans Are Turning to Clinical Trials
Diabetes touches nearly every American family. Roughly one in ten adults in the U.S. lives with the condition, and the numbers keep climbing. Managing it well means juggling blood sugar checks, medication timing, food choices, and regular visits to a care team. For many, the daily routine becomes exhausting, and some quietly give up on consistent care.
Clinical trials are stepping into that gap. In 2025 alone, the American Diabetes Association's 85th Scientific Sessions in Chicago highlighted results from the QWINT-1 trial, which showed that a once-weekly insulin called Efsitora matched the blood sugar control of daily insulin in adults with type 2 diabetes. Participants saw their A1c drop by about 1.3 percentage points, with many reaching targets near the 6.9 percent range. For the roughly one in four patients who skip or misuse daily basal insulin doses, a weekly option could remove a major barrier.
Meanwhile, researchers at institutions from Stanford to Boston Children's Hospital are running studies that pair digital tools with personal support. One Stanford program combines a diabetes-tailored weight management app with continuous glucose monitoring, compensating participants per study visit for their time. Another Boston-based trial compares a standard diet with a very low carbohydrate approach to understand how food choices shape glucose control in type 1 diabetes, offering up to $1,300 in financial compensation to volunteers.
What makes this moment unusual is the range of options. Trials now cover oral GLP-1 medications that do not require fasting, cell therapies for newly diagnosed type 1 diabetes, and even prototype systems that automate insulin dose adjustments using continuous glucose data. A recent evaluation of a CGM-informed basal insulin optimization system showed that providers accepted more than 96 percent of the system's dose recommendations, a promising sign for future automation.
What Participating in a Diabetes Trial Actually Looks Like
Before you decide, it helps to understand the process. Most trials follow a similar rhythm. You start with a screening visit where the research team reviews your medical history, runs labs, and checks your A1c against the study's eligibility criteria. If you qualify, you will be asked to sign an informed consent document that spells out the procedures, the potential risks, and your right to leave at any time.
Compensation varies widely by study type and length. Short observational studies might offer modest amounts per visit, while longer interventional trials with more demanding schedules tend to pay more. The Boston Children's type 1 diet study, for example, compensates up to $1,300 for the full commitment. Some device trials provide the technology and supplies at no cost to participants, which can be a meaningful benefit if you are uninsured or underinsured.
It is worth noting that most U.S. trials are covered by the sponsor rather than billed to your insurance. The study team typically handles the cost of the investigational drug, device, and study-related tests. Your regular diabetes care, unrelated medical needs, and travel to the study site usually remain your responsibility, so ask about travel reimbursement before you enroll.
Here is a practical comparison of common trial types you will find across the country:
| Trial Type | Example Research | Participant Profile | Likely Commitment | Main Benefits | Things to Consider |
|---|
| Medication (weekly insulin) | QWINT-1 Efsitora studies | Adults with type 2 diabetes not yet on insulin | 52 weeks plus follow-up | Fewer injections, simpler routine | Randomized assignment to treatment |
| Oral GLP-1 therapy | SOLSTICE elecoglipron trial | Adults with type 2 diabetes | Around 26 weeks | No needles, no fasting requirement | Dose escalation schedule |
| Device / CGM system | Smart basal insulin optimization | Adults with type 2 diabetes using insulin | Several weeks to months | Automated dose suggestions, detailed glucose data | Must wear extra study sensors |
| Diet and lifestyle | Low carbohydrate diet study | Adults with type 1 diabetes | Variable | Structured meals provided, compensation | Random assignment to diet group |
| Cell therapy | GNTI-122 recent-onset T1D study | Adults 18-55 newly diagnosed with type 1 diabetes | Up to 78 weeks | Potential to preserve insulin production | Phase 1 safety focus, frequent visits |
How to Find the Right Study Near You
The single best starting point is ClinicalTrials.gov, the federal registry that catalogs studies across the country. Search for your condition, your state, and whether you prefer studies that are currently recruiting. You can filter by age, sex, and study type, and each listing includes contact details for the research coordinator.
If you prefer a guided approach, reach out to a nearby academic medical center. Institutions like Stanford, UCSD, and Boston Children's Hospital run dedicated diabetes research programs with coordinators who match patients to open trials. You do not need to be an existing patient at most of these centers to participate, as the Boston Children's program explicitly states. Community health centers and endocrinology clinics in your area can also point you toward studies run by local research networks.
When you speak with a coordinator, come prepared with a short list of questions. Ask how randomization works and what happens if you receive a placebo. Confirm whether the study covers travel and parking. Clarify what happens after the trial ends, especially for medication trials, since access to the investigational drug typically stops once the study concludes. And always bring the details to your regular doctor. Your care team should know about any study you join so they can coordinate safely with the research staff.
A Few Final Thoughts
Diabetes management trials are not just experiments for scientists. They are real opportunities for real people to access emerging treatments, receive close monitoring, and shape the future of diabetes care in the U.S. Sarah, a 54-year-old school teacher in Ohio, told a research coordinator she joined a weekly insulin study mainly because she was tired of daily injections; after the trial, her A1c improved and she felt more in control of her day. Stories like hers are common across the country.
That said, participation is a personal decision. It requires time, travel, and a willingness to follow a study schedule. Talk it over with your doctor, ask honest questions, and only join a study you fully understand.
If you are curious about what is available near you, spend an hour browsing ClinicalTrials.gov or call the research office at a nearby medical center. The next breakthrough in diabetes care might depend on someone just like you saying yes.
研究の知恵